Skip to Main Content

Paper Details

Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.
Cell Host Microbe
118
2022
SARS, SARS-CoV-2, SARS-CoV-2 spike, human, humans, spike, spike protein
COVID-19, Humans, Mutation, SARS-CoV-2, Spike Glycoprotein, Coronavirus
Author NameAffiliation
Alba EscaleraIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Ana S Gonzalez-ReicheIcahn School of Medicine at Mount Sinai
Ignacio MenaIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Manon LaporteIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Rebecca L PearlIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Andrea FossatiQuantitative Biosciences Institute (QBI), University of California, USA J. David Gladstone Institutes san francisco
Raveen RathnasingheIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Hala AlshammaryIcahn School of Medicine at Mount Sinai
Adriana van de GuchteIcahn School of Medicine at Mount Sinai
Keith FarrugiaIcahn School of Medicine at Mount Sinai
Yiren QinHuffington Center for Cell-based Research in Parkinson's Disease, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Mehdi BouhaddouQuantitative Biosciences Institute (QBI), University of California, USA J. David Gladstone Institutes san francisco
Thomas KehrerIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Lorena Zuliani-AlvarezQuantitative Biosciences Institute (QBI), University of California, USA J. David Gladstone Institutes san francisco
David A MeekinsCollege of Veterinary Medicine, Kansas State University
Velmurugan BalaramanCollege of Veterinary Medicine, Kansas State University
Chester McDowellCollege of Veterinary Medicine, Kansas State University
Juergen A RichtCollege of Veterinary Medicine, Kansas State University
Goran BajicIcahn School of Medicine at Mount Sinai
Emilia Mia SordilloIcahn School of Medicine at Mount Sinai
Marion DejosezHuffington Center for Cell-based Research in Parkinson's Disease, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Thomas P ZwakaHuffington Center for Cell-based Research in Parkinson's Disease, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai
Nevan J Krogan (CM4AI)Icahn School of Medicine at Mount Sinai, USA Quantitative Biosciences Institute (QBI), University of California, USA J. David Gladstone Institutes san francisco
Viviana SimonIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Randy A AlbrechtIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
Harm van BakelIcahn School of Medicine at Mount Sinai, USA Icahn Institute for Data Science and Genomic Technology
Harm van BakelIcahn School of Medicine at Mount Sinai, USA Icahn Institute for Data Science and Genomic Technology
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute, USA The Tisch Cancer Institute
Teresa AydilloIcahn School of Medicine at Mount Sinai, USA Global Health and Emerging Pathogens Institute
  • 1 - 29

Datasets